Berger, Daniel S., MD
FDA reports that the clinical-investigator restrictions were removed for Berger, Daniel S., MD on 10 Sep 2014. This source entry is excluded from current screening matches.
Source evidence summary
What this FDA outcome means
The restrictions in the FDA agreement no longer apply. The investigator is again eligible to receive investigational products subject to applicable requirements; the earlier proceeding remains part of the published history.
Chronology in the published evidence
FDA initiated disqualification proceedings and offered an opportunity to explain (NIDPOE).
FDA recorded the outcome “Restrictions Removed”.
- FDA status
- Restrictions Removed
- Date of FDA status
- Recorded value
2014-09-10
Programs recorded by the publisher
- FDA clinical investigator proceedings
A matching name alone does not establish identity. Check the original publisher’s measures, dates and exceptions before deciding how this entry applies to a person, organization or asset.
Check your own customers or vendors.
Screen your clinical investigators against the FDA Clinical Investigator Disqualification Proceedings and other available sources with SanctionsKit.
Compare names, aliases and dates of birth where available. Review possible matches and save the evidence.
250 free live checks. No card needed. Share them across the API and dashboard. Your first workspace gets them once, with no monthly reset. Choose a paid plan for more.
Cite, download or correct this record
Cite or save this record
View citation text
Berger, Daniel S., MD. United States Food and Drug Administration: Clinical Investigators—Disqualification Proceedings. This source record is excluded from current screening matches. Official source: https://www.accessdata.fda.gov/scripts/SDA/sdDetailNavigation.cfm?id=CD5EDDB44C9EAA37E040A8C0754D57E1&sd=clinicalinvestigatorsdisqualificationproceedings SanctionsKit: https://www.sanctionskit.com/records/us-fda-restricted/berger-daniel-s-md--id-Q0Q1RUREQjQ0QzlFQUEzN0UwNDBBOEMwNzU0RDU3RTE Source version: us-fda-restricted:1.0.0:63611f4f6595671d29a47db422ac9b490b2e935b4c4e782d39673dda8fdcb5b9. Retrieved: 2026-11-01T19:51:22.442Z. Last checked: 2026-11-01T19:51:22.442Z. This cites one source record. Check the official source for what the listing covers and when it applies.
This is a current view and may change. The citation and CSV name the source version you read.
Report a correction with the record link and the official source that supports it. Help for journalists and researchers.
Source context and scope
This entry is excluded from current screening matches. Matching eligibility is separate from a legal conclusion. Review the publisher’s status, dates and exceptions.
Status as described by the source
- Current restriction matching
- Historical proceeding; excluded from current restriction matching
Scope and limitations
- Status scope
- FDA reports restored or retained eligibility. This historical proceeding is not treated as a current restriction; consult any referenced agreement.
Further source details
- Record type
- FDA clinical investigator disqualification proceeding
- FDA center
- CDER
- Date NIDPOE Issued
- Recorded value
2009-11-27
Continue reviewing this source.
Compare the original evidence and explore other records in FDA Clinical Investigator Disqualification Proceedings.